113 related articles for article (PubMed ID: 18483316)
1. Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity.
Mijatovic T; De Nève N; Gailly P; Mathieu V; Haibe-Kains B; Bontempi G; Lapeira J; Decaestecker C; Facchini V; Kiss R
Mol Cancer Ther; 2008 May; 7(5):1285-96. PubMed ID: 18483316
[TBL] [Abstract][Full Text] [Related]
2. Reevesioside A, a cardenolide glycoside, induces anticancer activity against human hormone-refractory prostate cancers through suppression of c-myc expression and induction of G1 arrest of the cell cycle.
Leu WJ; Chang HS; Chan SH; Hsu JL; Yu CC; Hsu LC; Chen IS; Guh JH
PLoS One; 2014; 9(1):e87323. PubMed ID: 24475272
[TBL] [Abstract][Full Text] [Related]
3. The cardenolide UNBS1450 is able to deactivate nuclear factor kappaB-mediated cytoprotective effects in human non-small cell lung cancer cells.
Mijatovic T; Op De Beeck A; Van Quaquebeke E; Dewelle J; Darro F; de Launoit Y; Kiss R
Mol Cancer Ther; 2006 Feb; 5(2):391-9. PubMed ID: 16505114
[TBL] [Abstract][Full Text] [Related]
4. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
[TBL] [Abstract][Full Text] [Related]
5. Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers.
Mijatovic T; Mathieu V; Gaussin JF; De Nève N; Ribaucour F; Van Quaquebeke E; Dumont P; Darro F; Kiss R
Neoplasia; 2006 May; 8(5):402-12. PubMed ID: 16790089
[TBL] [Abstract][Full Text] [Related]
6. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways.
Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH
Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069
[TBL] [Abstract][Full Text] [Related]
7. Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene.
Koh CM; Gurel B; Sutcliffe S; Aryee MJ; Schultz D; Iwata T; Uemura M; Zeller KI; Anele U; Zheng Q; Hicks JL; Nelson WG; Dang CV; Yegnasubramanian S; De Marzo AM
Am J Pathol; 2011 Apr; 178(4):1824-34. PubMed ID: 21435462
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
9. Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells.
Lefranc F; Mijatovic T; Kondo Y; Sauvage S; Roland I; Debeir O; Krstic D; Vasic V; Gailly P; Kondo S; Blanco G; Kiss R
Neurosurgery; 2008 Jan; 62(1):211-21; discussion 221-2. PubMed ID: 18300910
[TBL] [Abstract][Full Text] [Related]
10. The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.
Rebello RJ; Kusnadi E; Cameron DP; Pearson HB; Lesmana A; Devlin JR; Drygin D; Clark AK; Porter L; Pedersen J; Sandhu S; Risbridger GP; Pearson RB; Hannan RD; Furic L
Clin Cancer Res; 2016 Nov; 22(22):5539-5552. PubMed ID: 27486174
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression.
Schrecengost RS; Keller SN; Schiewer MJ; Knudsen KE; Smith CD
Mol Cancer Res; 2015 Dec; 13(12):1591-601. PubMed ID: 26271487
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer.
Carabet LA; Lallous N; Leblanc E; Ban F; Morin H; Lawn S; Ghaidi F; Lee J; Mills IG; Gleave ME; Rennie PS; Cherkasov A
Eur J Med Chem; 2018 Dec; 160():108-119. PubMed ID: 30326371
[TBL] [Abstract][Full Text] [Related]
13. Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450.
Cerella C; Muller F; Gaigneaux A; Radogna F; Viry E; Chateauvieux S; Dicato M; Diederich M
Cell Death Dis; 2015 Jun; 6(6):e1782. PubMed ID: 26068790
[TBL] [Abstract][Full Text] [Related]
14. Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells.
Estrada AC; Syrovets T; Pitterle K; Lunov O; Büchele B; Schimana-Pfeifer J; Schmidt T; Morad SA; Simmet T
Mol Pharmacol; 2010 Mar; 77(3):378-87. PubMed ID: 20018812
[TBL] [Abstract][Full Text] [Related]
15. Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.
Ciccarelli C; Di Rocco A; Gravina GL; Mauro A; Festuccia C; Del Fattore A; Berardinelli P; De Felice F; Musio D; Bouché M; Tombolini V; Zani BM; Marampon F
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1685-1699. PubMed ID: 29959569
[TBL] [Abstract][Full Text] [Related]
16. RB activation and repression of C-MYC transcription precede apoptosis of human prostate epithelial cells.
Zhao X; Day ML
Urology; 2001 May; 57(5):860-5. PubMed ID: 11337282
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
[TBL] [Abstract][Full Text] [Related]
18. Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway.
Thamilselvan V; Menon M; Thamilselvan S
Int J Cancer; 2011 Dec; 129(12):2916-27. PubMed ID: 21472727
[TBL] [Abstract][Full Text] [Related]
19. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
20. Ascleposide, a natural cardenolide, induces anticancer signaling in human castration-resistant prostatic cancer through Na
Leu WJ; Wang CT; Hsu JL; Chen IS; Chang HS; Guh JH
Prostate; 2020 Mar; 80(4):305-318. PubMed ID: 31905252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
